BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30471679)

  • 1. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.
    Müller F; Liechti ME; Lang UE; Borgwardt S
    Prog Brain Res; 2018; 242():159-177. PubMed ID: 30471679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.
    Dos Santos RG; Osório FL; Crippa JAS; Hallak JEC
    Neurosci Biobehav Rev; 2016 Dec; 71():715-728. PubMed ID: 27810345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of lysergic acid diethylamide (LSD) on resting brain function.
    Müller F; Borgwardt S
    Swiss Med Wkly; 2019 Sep; 149():w20124. PubMed ID: 31568558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
    Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
    Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.
    McCulloch DE; Madsen MK; Stenbæk DS; Kristiansen S; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    J Psychopharmacol; 2022 Jan; 36(1):74-84. PubMed ID: 34189985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice.
    Grandjean J; Buehlmann D; Buerge M; Sigrist H; Seifritz E; Vollenweider FX; Pryce CR; Rudin M
    Neuroimage; 2021 Jan; 225():117456. PubMed ID: 33069863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.
    Pallavicini C; Vilas MG; Villarreal M; Zamberlan F; Muthukumaraswamy S; Nutt D; Carhart-Harris R; Tagliazucchi E
    Neuroimage; 2019 Oct; 200():281-291. PubMed ID: 31247301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.
    McCulloch DE; Knudsen GM; Barrett FS; Doss MK; Carhart-Harris RL; Rosas FE; Deco G; Kringelbach ML; Preller KH; Ramaekers JG; Mason NL; Müller F; Fisher PM
    Neurosci Biobehav Rev; 2022 Jul; 138():104689. PubMed ID: 35588933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
    Sousa TR; Rema J; Machado S; Novais F
    Curr Top Med Chem; 2022; 22(15):1250-1260. PubMed ID: 34852736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.
    Girn M; Roseman L; Bernhardt B; Smallwood J; Carhart-Harris R; Nathan Spreng R
    Neuroimage; 2022 Aug; 256():119220. PubMed ID: 35483649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging: a scanner, colourfully.
    Roiser JP; Rees G
    Curr Biol; 2012 Apr; 22(7):R231-3. PubMed ID: 22497939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelics and mental health: a population study.
    Krebs TS; Johansen PØ
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced repertoire of brain dynamical states during the psychedelic experience.
    Tagliazucchi E; Carhart-Harris R; Leech R; Nutt D; Chialvo DR
    Hum Brain Mapp; 2014 Nov; 35(11):5442-56. PubMed ID: 24989126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.
    Barrett FS; Krimmel SR; Griffiths RR; Seminowicz DA; Mathur BN
    Neuroimage; 2020 Sep; 218():116980. PubMed ID: 32454209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.
    Carhart-Harris RL; Leech R; Erritzoe D; Williams TM; Stone JM; Evans J; Sharp DJ; Feilding A; Wise RG; Nutt DJ
    Schizophr Bull; 2013 Nov; 39(6):1343-51. PubMed ID: 23044373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained effects of single doses of classical psychedelics in humans.
    Knudsen GM
    Neuropsychopharmacology; 2023 Jan; 48(1):145-150. PubMed ID: 35729252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered network hub connectivity after acute LSD administration.
    Müller F; Dolder PC; Schmidt A; Liechti ME; Borgwardt S
    Neuroimage Clin; 2018; 18():694-701. PubMed ID: 29560311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
    Carhart-Harris RL; Erritzoe D; Williams T; Stone JM; Reed LJ; Colasanti A; Tyacke RJ; Leech R; Malizia AL; Murphy K; Hobden P; Evans J; Feilding A; Wise RG; Nutt DJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2138-43. PubMed ID: 22308440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.
    Gaddis A; Lidstone DE; Nebel MB; Griffiths RR; Mostofsky SH; Mejia AF; Barrett FS
    Neuroimage; 2022 Oct; 260():119434. PubMed ID: 35792293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.